Hantavirus global briefing — August 16, 2026: UKHSA finds no UK Andes cases as Zhejiang rodents carry Seoul virus

Executive read

The newest evidence changes the reservoir picture more than the human case count.

United Kingdom: A UK Health Security Agency report published on 13 August, covering the week ending 9 August, says no Andes hantavirus infection has been reported in the UK. Seoul hantavirus is the only species identified in the country, and it does not spread between people. 1
China reservoir watch: A July 30 study from rural Lanxi, Zhejiang, detected hantavirus carriage in 5 of 350 rodents (1.43%). The two sequenced strains were Seoul virus. 2
Alert layer: ECDC's week-33 bulletin, covering 8–14 August, contains no hantavirus or Andes-virus item. That is a bounded no-new-ECDC-escalation finding, not a Europe-wide incidence estimate. 3

No new authoritative human case denominator from Asia-Pacific or another region was verified in the daily window ending 15 August 2026. The latest readable Chile balance also remains 46 confirmed infections and 18 deaths through 28 July; the reported Rengo case has not been reconciled into that national total. 4

What the UK report adds

The UKHSA entry is a current official status check rather than a new British case report. It records the imported Andes-virus investigation in France and Spain and then states that no Andes infection has been reported in the UK to date. The report also distinguishes the country's established Seoul-virus signal from the imported Andes event: Seoul virus has been identified in the UK, but the UK guidance says it does not spread between people. 1

That distinction matters for surveillance. A travel-associated Andes case in Europe can justify contact tracing because Andes virus has documented person-to-person transmission under close exposure. A Seoul-virus detection in a UK rodent or human does not create the same human-transmission pathway. The report therefore supports a two-track watch: imported Andes exposure in people, and endemic rodent-associated Seoul virus as a separate background risk.

The UK report's underlying Andes entry describes a French-Argentine tourist who travelled through France in late July and was isolating with family in Galicia. It records two asymptomatic family contacts under 42-day quarantine and says the event was unrelated to the M/V Hondius cluster. These details are dated to the 6–7 August reporting period, so they should not be counted as a new case or a new European outbreak. 1

Research watch: a concrete reservoir signal from Zhejiang

Paper: Prevalence and Genetic Diversity of Zoonotic Leptospira and Hantavirus in Rodents, Lanxi City, 2023–2025

Publication and design: Qianqian Xu and colleagues, Vector-Borne and Zoonotic Diseases, published ahead of print on 30 July 2026. The study examined rodents from rural Lanxi City in Zhejiang Province. 2
Sampling: Researchers captured 350 rodents between April 2023 and August 2025, collected liver and kidney tissue, used real-time fluorescent PCR, and sequenced positive samples. Rattus norvegicus accounted for 80% of the catch. 2
Hantavirus result: Five of 350 rodents carried hantavirus nucleic acid, giving a reported carriage rate of 1.43%. The positive animals were mainly R. norvegicus and Rattus flavipectus. The study identified all hantavirus isolates as Seoul virus. 2
Genetic result: Two sequenced Seoul-virus strains were close to domestic Seoul-virus strains from 2021 but showed only 86.08–86.81% nucleotide homology with the vaccine strains cited by the authors. The authors call for further serological validation and targeted monitoring. 2
Evidence limit: This is an observational study from one rural city, using samples collected over 2023–2025. It measures local rodent carriage and sequence variation; it does not measure current human incidence, prove vaccine failure, or establish that the detected strains caused a human outbreak. 2

Read-or-skip decision: Open the paper if you need a concrete example of how local Seoul-virus surveillance can add genomic and host information to a human-case monitoring system. Skip it as a source for today's case count: its sampling period and geographic scope cannot support a current global estimate.

Keep the evidence layers separate

Evidence layer	Latest verified position	What it supports	What it cannot support
Human transmission watch	UKHSA reports no UK Andes cases to date; the France-Spain event remains a targeted contact-tracing investigation. 1	Continued follow-up of close contacts and attention to any compatible illness.	A claim of zero European hantavirus infections or a new continent-wide outbreak.
Rodent reservoir watch	Lanxi recorded 5/350 hantavirus-positive rodents, all sequenced isolates being Seoul virus. 2	Local reservoir surveillance and strain-characterisation work.	A real-time human-risk estimate for Zhejiang or Asia-Pacific.
European alert layer	ECDC week 33 lists no hantavirus or Andes-virus item. 3	No new escalation is visible in that ECDC bulletin.	Zero incidence across European countries.
Americas denominator	The latest readable Chile balance is 46 infections and 18 deaths through 28 July, while the Rengo case remains unreconciled with that total. 4	A dated national baseline and a denominator-reconciliation watchpoint.	A revised Chile total or a new fatality count.

WHO's separate M/V Hondius event remains a closed comparator: the latest WHO notice says it no longer poses a public-health risk and that further related transmission is not expected. 5 No newer hantavirus-specific CDC notice was verified in this edition; the latest accessible CDC notice remains a historical response-status boundary, not a current US incidence estimate. 6

What to watch next

France and Spain: whether any remaining close contact develops compatible illness or tests positive during the follow-up period. A larger contact count alone would not be a case count.
Chile: a readable Minsal or ISP table that reconciles the 46/18 national balance with the confirmed Rengo case. 4
Asia-Pacific: a human case denominator or a new rodent-abundance or reservoir-infection measurement that can be compared across places and dates.
Research: validation of the Lanxi sequence finding through serology, broader sampling, or a demonstrated clinical or vaccine-relevance endpoint. 2

The practical read for this morning is narrow: the official human-transmission picture has not escalated, while the Zhejiang study supplies a measurable local reservoir signal. Those findings belong on adjacent watchlists, not in one combined outbreak total.